X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Lupin Ltd Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Lupin Ltd Quarterly Results   (LUPL)

Here are the latest quarterly results of Lupin Ltd. For more details, see the Lupin Ltd financial fact sheet and Lupin Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Lupin Ltd Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m44,39442,90544,82942,53338,69639,52039,75640,338 
Other income Rs m8262711,0364533207402841,449 
Turnover Rs m45,22043,17645,86542,98639,01640,26040,04041,788 
Expenses Rs m31,31432,62432,67035,12631,55230,98932,87333,251 
Gross profit Rs m13,07410,31512,1587,8137,6848,5516,884-7,615 
Depreciation Rs m2,0272,1122,3092,6742,6052,7222,8042,728 
Interest Rs m320263459406439479540585 
Profit before tax Rs m11,5548,21110,4265,1864,9596,0913,825-9,480 
Tax Rs m2,7341,5894,0951,3671,3681,5411,608-1,632 
Profit after tax Rs m8,8206,6226,3313,8193,5914,5502,217-7,848 
Gross profit margin %29.524.027.118.419.921.617.3-18.9 
Effective tax rate %23.719.439.326.427.625.342.017.2 
Net profit margin %19.915.414.19.09.311.55.6-19.5 
Diluted EPS Rs 19.5 14.7 14.0 8.5 8.0 10.1 4.9 -17.4  
Diluted EPS (TTM) Rs 58.2 63.9 66.2 56.7 45.1 40.5 31.4 5.6  
 Subscriber Feature View   View View View View View    
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   ELDER PHARMA  DISHMAN PHARMA  ALEMBIC LTD  INDOCO REMEDIES  CIPLA  

Compare LUPIN LTD With:   ELDER PHARMA  DISHMAN PHARMA  ALEMBIC LTD  INDOCO REMEDIES  CIPLA  

Compare LUPIN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade in Red; IPO Buzz, and Top Stocks in Action(Pre-Open)

On Wednesday, share markets in India opened in green and went on to hit a new all-time high. However, selling during the day meant that the benchmark indices ended the day in red.

Views on news

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Jul 18, 2018 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON LUPIN LTD

LUPIN LTD - VENUS REMEDIES COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS